Skip to main content

Rallybio Corp

RLYB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001739410

No open-market purchases or sales by Rallybio Corp insiders were filed in the last 90 days; 37 institutions reported holding it in 13F filings for Q2 2026, worth $65.0M in total; Viking Global Investors is the only superinvestor holding it.

Q4 2024 vs. Q3 2024

How the institutions holding Rallybio Corp changed between Q3 2024 and Q4 2024.

All holders in Q4 2024All holders in Q3 2024

13F holders of RLYB: Q3 2024 compared with Q4 2024
MeasureQ3 2024Q4 2024Change
Holders49490
Shares31.2M32.4M+1.22M (+3.9%)
Value$36.5M$31.1M−$5.39M (−14.8%)

New holders (7)

Institutions that held Rallybio Corp at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to RLYB in Q4 2024
InstitutionSharesValue% of portfolio
Allostery Investments LP803,398$771.3K1.51%
AJU IB Investment Co., Ltd.754,678$724.5K0.71%
Engineers Gate Manager LP35,736$34.3K0.00%
Great Valley Advisor Group, Inc.15,000$14.4K0.00%
Mercer Global Advisors Inc10,000$9.60K0.00%
SBI Securities Co., Ltd.5,356$5.14K0.00%
BNP Paribas Arbitrage, SA1,100$1.06K0.00%

Sold out (7)

Institutions that held Rallybio Corp at the end of Q3 2024 and filed for Q4 2024 without it.

Institutions that sold out of RLYB in Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
Susquehanna International Group, LLP92,333$108.0K
Jane Street Group, LLC22,275$26.1K
HarbourVest Partners LLC21,877$25.6K
Dimensional Fund Advisors LP21,203$24.8K
Qube Research & Technologies Ltd10,664$12.5K
Catalyst Funds Management Pty Ltd7,800$9.13K
Russell Investments Group, Ltd.1,049$1.23K